A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Senolytics against Covid-19?
[unknown]
Les sénolytiques contre la Covid-19 ? - Chroniques génomiques
2021
Les sénolytiques contre la Covid-19 ? - Chroniques génomiques
Preserved Fulltext
The elimination of some senescent cells by « senolytic » compounds can greatly improve the health of aged mice and in some cases reverse the effects of aging. Using a microbial exposure system that closely models coronavirus infection, it is possible to largely protect old mice from the effects of viral infection. This immediately suggests clinical application of the approach, and is the aim of ongoing phase II clinical trials in Covid-19 patients.
doi:10.1051/medsci/2021161
pmid:34851287
fatcat:vt7xazo5aved5nw5iu47ija3r4